NTLA Market Cap & Key Metrics
Intellia Therapeutics, Inc.
$11.43
-$0.48(-4.03%)
51
Overall
60
Value
54
Tech
39
Quality
Market Cap
$1.60B
Volume
5.44M
52W Range
$7.95 - $28.25
Target Price
$22.33
NTLA market cap is $1.60B. This page lists Intellia Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
NTLA Key Metrics
- Market cap
- $1.60B
- EPS estimate, current year
- $-3.21
- EPS growth, 3-year
- +14.80%
- Value score
- 60
- Quality score
- 39
- Technical score
- 54
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $67.67M | $57.88M | $36.27M | $52.12M | $33.05M |
| EBITDA | -$396.77M | -$508.74M | -$472.22M | -$466.61M | -$253.40M |
| EPS | $-3.81 | $-5.25 | $-5.42 | $-6.16 | - |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $11.43 | -4.0% | 5.44M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW